Abbott’s Deal for Alere Turns Nasty as Firms Brawl in Court

  • Unsealed Alere suit provides new details on faltering merger
  • Abbott counters with allegations of Alere coaching witnesses

Abbott Laboratories’ stalled acquisition of Alere Inc. is turning into an all-out brawl between the two makers of diagnostic testing devices, with both trading accusations of wrongdoing.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.